“It’s a welcome validation of our innovative, patented technology and a
confirmation that we are addressing a really significant problem with a
globally-relevant market opportunity”

The grant was awarded to assist in the development of an innovative
automatic blood glucose control system, Glucostat, developed by
Flowsion. Glucostat is expected to reduce mortality, morbidity, length
of stay and treatment costs dramatically for intensive care patients
compared to existing technologies.

“It’s a welcome validation of our innovative, patented technology and a
confirmation that we are addressing a really significant problem with a
globally-relevant market opportunity,” said Hans Jorgen Pedersen, CEO of
Flowsion. “Flowsion has already performed clinical studies with the
system so we now that Glucostat will fulfil the demands of the intensive
care units.”

With 5-8 % success rate the European Innovation Council SME Instrument
awards are exceptionally competitive, and only 3018 companies across
Europe were awarded a grant until now.

“This kind of technology is really crucial for intensive care medicine,
where patients’ lifes are threatened every day. Glucose control has
proven to be very difficult to perform for the intensive care units in
hospitals world wide, and now getting a system that automatically helps
performing blood glucose control will increase survival rate and lower
treatment costs at the same time” said Hans Jorgen Pedersen. “We’ve
carefully studied several technologies and designed a solution that is
really elegant and simple to use, but that also delivers an enormous
value for patients, doctors, nurses and hospitals.”

The SME Instrument programme is designed to assist
internationally-oriented SMEs in implementing high-risk and
high-potential innovation ideas. It aims at supporting projects with a
European dimension that lead to major changes in how business is done.

About Flowsion Flowsion is a European medical device
company focusing exclusively on the needs of intensive care unit
patients. Flowsion will launch new projects later on with other
continuous measurement and control technologies for the ICU patients.
More information can be found at: http://flowsion.dk